Morgan, Pooranee K. http://orcid.org/0009-0005-8242-4492
Pernes, Gerard http://orcid.org/0000-0001-6524-3255
Huynh, Kevin
Giles, Corey http://orcid.org/0000-0002-6050-1259
Paul, Sudip
Smith, Adam Alexander T. http://orcid.org/0000-0003-4593-3042
Mellett, Natalie A.
Liang, Amy
van Buuren-Milne, Tilly
Veiga, Camilla Bertuzzo http://orcid.org/0000-0001-6989-9374
Collins, Thomas J. C. http://orcid.org/0000-0002-8044-2815
Xu, Yangsong http://orcid.org/0000-0003-2901-7642
Lee, Man K. S.
De Silva, T. Michael http://orcid.org/0000-0001-6351-7304
Meikle, Peter J. http://orcid.org/0000-0002-2593-4665
Lancaster, Graeme I. http://orcid.org/0000-0002-2924-7758
Murphy, Andrew J. http://orcid.org/0000-0001-7039-7777
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (GNT1189012, GNT1197190, GNT2009965, GNT1194329)
State Government of Victoria (Operational support program)
Article History
Received: 13 March 2023
Accepted: 19 February 2024
First Online: 8 April 2024
Competing interests
: G.I.L., A.J.M., P.J.M., S.P. and P.K.M. have filed a patent application in Australia (application no. 2023900331) relating to the composition of plasmalogens within immune cells, which forms a partial basis for the formulation of plasmalogen supplements as a nutritional way to impact cell function. The other authors declare no competing interests.